HomeStock ScreenerExpleo SolutionsIntrinsic Value

Expleo Solutions Intrinsic Value

Expleo Solutions (EXPLEOSOL) median intrinsic value is ₹884.98 from 9 valuation models (range ₹485–₹1680), vs current price ₹881.95 — +0.3% upside (Trading Near Calculated Value), margin of safety 0.3%. Check Expleo Solutions market worth to track the company's total market size over time.

Market Price (CMP)
₹881.95
Primary Intrinsic Value
₹1288.80
Market Cap
₹1411 Cr
+0.3% Upside
Median Value
₹884.98
Value Range
₹485 - ₹1680
Assessment
Trading Near Calculated Value
Safety Margin
0.3%

EXPLEOSOL Valuation Methods Summary — DCF, Graham Number & P/E

Expleo Solutions intrinsic value across 9 models vs current price ₹881.95 — upside/downside and value range per method. See Expleo Solutions P/B ratio trends to compare market price against book value per share.

Method Type Intrinsic Value Range Upside/Downside Details
P/E Based Valuation earnings ₹1288.80 ₹1031.04 - ₹1546.56 +46.1% EPS: ₹107.40, Sector P/E: 12x
Book Value Method asset ₹485.00 ₹436.50 - ₹533.50 -45.0% Book Value/Share: ₹485.00, P/B: 1.0x
Revenue Multiple Method revenue ₹602.00 ₹541.80 - ₹662.20 -31.7% Revenue/Share: ₹752.50, P/S: 0.8x
EBITDA Multiple Method earnings ₹855.00 ₹769.50 - ₹940.50 -3.1% EBITDA: ₹228.00Cr, EV/EBITDA: 6x
Simple DCF (5Y) dcf ₹1018.75 ₹815.00 - ₹1222.50 +15.5% CF Growth: 15.0%, Discount: 15%
PEG Ratio Method growth ₹687.36 ₹618.62 - ₹756.10 -22.1% EPS Growth: 8.0%, Fair P/E: 6.4x
Growth Adjusted P/E growth ₹884.98 ₹796.48 - ₹973.48 +0.3% Revenue Growth: 6.0%, Adj P/E: 8.2x
ROE Based Valuation profitability ₹1680.00 ₹1512.00 - ₹1848.00 +90.5% ROE: 21.6%, P/E Multiple: 16x
Graham Defensive Method conservative ₹970.00 ₹873.00 - ₹1067.00 +10.0% EPS: ₹107.40, BVPS: ₹485.00
Method Types: Earnings Asset DCF Growth Dividend Conservative

EXPLEOSOL Intrinsic Value vs Market Price — All Valuation Models

Expleo Solutions fair value range ₹485–₹1680 vs current market price ₹881.95 across 9 valuation models. For current market price and key ratios, visit EXPLEOSOL stock price BSE.

EXPLEOSOL Intrinsic Value Analysis — Undervalued or Overvalued?

Expleo Solutions median intrinsic value ₹884.98, current price ₹881.95 — Trading Near Calculated Value by 0.3%, margin of safety 0.3%.

What is the intrinsic value of EXPLEOSOL?

Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Expleo Solutions (EXPLEOSOL) is ₹884.98 (median value). With the current market price of ₹881.95, this represents a +0.3% variance from our estimated fair value.

The valuation range spans from ₹485.00 to ₹1680.00, indicating ₹485.00 - ₹1680.00.

Is EXPLEOSOL undervalued or overvalued?

Based on our multi-method analysis, Expleo Solutions (EXPLEOSOL) appears to be trading near calculated value by approximately 0.3%.

EXPLEOSOL Financial Health — Key Ratios vs Industry Benchmarks

Expleo Solutions financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.

Financial Metric Current Value Industry Benchmark Assessment Impact on Valuation
Current Ratio 29.62 Industry Standard: 2.0+ Above 2.0 Measures short-term liquidity capacity
Return on Equity 21.6% Industry Standard: 15%+ Above 15% Measures shareholder return efficiency
Operating Margin 15.0% Industry Standard: 20%+ Above 10% Indicates operational efficiency level
Asset Turnover Ratio 1.30x Industry Standard: 1.0x+ Above 1.0x Measures asset utilization efficiency

EXPLEOSOL Cash Flow Quality — Operating & Free Cash Flow

Expleo Solutions operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.

Period Operating Cash Flow Free Cash Flow Cash Flow Quality Sustainability Score
March 2026 ₹120 Cr ₹120 Cr Positive Free Cash Flow 8/10
March 2025 ₹179 Cr ₹154 Cr Positive Free Cash Flow 8/10
March 2024 ₹71 Cr ₹55 Cr Positive Free Cash Flow 8/10
March 2023 ₹23 Cr ₹5 Cr Positive Free Cash Flow 7/10
March 2022 ₹24 Cr ₹24 Cr Positive Free Cash Flow 8/10